PREPARATIONS: Powder For Injection: 5 g/vial
DRUG INTERACTIONS: Hydroxocobalamin drug interaction studies have not been conducted.
PREGNANCY AND BREASTFEEDING SAFETY:
- Hydroxocobalamin has not been adequately studied in pregnant women.
- It is not known whether hydroxocobalamin is secreted in breast milk. Hydroxocobalamin may be given to nursing mothers in life-threatening situations. Breastfeeding should be stopped after receiving hydroxocobalamin.
- Powder should be stored at room temperature, 15 C to 30 C (59 F to 86 F).
- After mixing with liquid it may be stored for up to 6 hours at a temperature not exceeding 40 C (104 F).
- It should not be frozen, and any unused portion should be discarded after 6 hours.
- The recommended initial dose is 5 g (one vial) administered by intravenous infusion over 15 minutes.
- A second 5 g dose may be administered if the response is not adequate.
- The maximum total dose is 10 g.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?
Use the pill identifier tool on RxList.